Table of conTenTs Welcome address II about GasTRo 2009, UeGW ...

More documents

Recommendations

Info

acknoWleDGeMenTs GASTRO 2009 UEGW/WCOG, London gratefully acknowledges the support of the following companies: (as per September 2009) AstraZeneca Olympus Schering-Plough XIV PReMIUM PaRTneR Abbott MaJoR sPonsoR Fujinon (Europe) GmbH Pentax Europe GmbH Visit London
GeneRal sPonsoRs a Actial Pharmaceutica Lda AIGE – Interamerican Association of Gastro enterology Alfa Wassermann SpA Alton (Shanghai) Medical Instruments Co., Ltd. APDW 2010 & Malaysian Society of Gastroenterology and Hepatology APSDE – The Asian-Pacific Society for Digestive Endoscopy ASGE – American Society for Gastro intestinal Endoscopy Avantis Medical Systems, Inc. Axcan Pharma S.A. b Barrx Medical Bedfont Scientific Ltd. Belimed AG Biocodex Biohit Oyj BioMed Central BMJ Group Boston Scientific Bracco Diagnostics Inc. BRACCO International B.V. BSG – British Society of Gastroenterology Bühlmann Laboratories AG c Calpro AS Casen Fleet S.L.U. CBC (Deutschland) GmbH Chonqqing Jinshan Science & Technology Inc. Beijing Office Coeliac UK Conmed UK Cook Medical Custom Ultrasonics D DANONE (c/o Allidura) DDW – Digestive Disease Week Dr. Falk Pharma GmbH acknoWleDGeMenTs e EASL – European Association for the Study of the Liver ECCO – European Crohn‘s and Colitis Organisation EDS – European Digestive Surgery EFCCA – European Federation of Crohn's & Ulcerative Colitis Association EGYPT GASTRO HEP Eisai Europe Ltd. & Janssen-Cilag ELLA-CS, s.r.o. Elsevier EndoChoice Endo-Flex GmbH Endoscopy UK Limited Endosoft BV EPC – European Pancreatic Club Epigenomics ERBE Elektromedizin GmbH ESGE – European Society of Gastrointestinal Endoscopy ESNM – European Society of Neurogastroenterology and Motility ESPCG – European Society of Coloproctology EUMEDICA Euroimmun AG Europacolon f Ferring Pharmaceuticals Fresenius Kabi Deutschland GmbH G GE Healthcare GI Health Foundation Given Imaging Glaxosmithkline H Hitachi Medical Systems Europe Holding AG I Imedex – WCGI – World Congress of GI Cancer Immersion Immundiagnostik AG Infai GmbH Institut Rosell – L‘Allemand IntroMedic Inverness Medical XV
Page 1 and 2: Welcome address II about GasTRo 200
Page 3 and 4: Anthony T. R. Axon President, OMED
Page 5 and 6: InVITaTIon GASTRO 2009 UEGW/WCOG, L
Page 7 and 8: Professor Guido Tytgat, The Netherl
Page 9 and 10: ABOUT UEGF - THE VOICE OF EUROPEAN
Page 11 and 12: In creating the WGO Training Center
Page 13: oMeD - WoRlD oRGanIsaTIon of DIGesT
Page 17 and 18: CONGRESS INFORMATION
Page 19 and 20: ReGIsTRaTIon Desk Opening Hours Fri
Page 21 and 22: The Press Centre is managed by the
Page 23 and 24: 6 conGRess InfoRMaTIon Watford 9 8
Page 25 and 26: - Promoting Global Digestive Health
Page 27 and 28: oPenInG PlenaRY sessIon The Plenary
Page 29 and 30: GI nURses 2009 - esGena/sIGnea conf
Page 31 and 32: SCIENTIFIC PROGRAMME
Page 33 and 34: Time Halls 09:00 - 10:30 11:00 - 16
Page 35 and 36: oVeRVIeW - MonDaY, noVeMbeR 23, 200
Page 37 and 38: oVeRVIeW - TUesDaY, noVeMbeR 24, 20
Page 39 and 40: oVeRVIeW - WeDnesDaY, noVeMbeR 25,
Page 41 and 42: GASTRO 2009 YOUNG CLINICIANS PROGRA
Page 43 and 44: YcP coRe-WoRksHoP PRoGRaMMe THe bUl
Page 45 and 46: POSTGRADUATE TEACHING PROGRAMME
Page 47 and 48: 11:20 - 11:40 Detection of early up
Page 49 and 50: 11:00 - 14:00 PARALLEL SESSION 3 /
Page 51 and 52: sUnDaY, noVeMbeR 22, 2009 08:30 - 0
Page 53 and 54: PosTGRaDUaTe TeacHInG PRoGRaMMe 11:
Page 55 and 56: PROGRAMME PER DAY
Page 57 and 58: 11:07 - 11:13 OP007 ENDOSCOPIC SUBM
Page 59 and 60: 11:00 - 11:10 OP017 INFLUENCE OF PA
Page 61 and 62: 12:00 - 12:10 OP032 OBJECTIVE PREDI
Page 63 and 64: 14:20 - 14:30 OP049 EFFECTS OF BONE
Page 65 and 66:
15:10 - 15:20 OP062 WEIGHT GAIN AFT
Page 67 and 68:
15:00 - 15:10 OP079 FIRSTDEGREE R
Page 69 and 70:
14:20 - 14:30 OP096 IBS SUBTYPING B
Page 71 and 72:
fRee PaPeR sessIon 15:45 - 17:15 N7
Page 73 and 74:
sYMPosIUM 15:45 - 17:15 Platinum 3/
Page 75 and 76:
17:05 - 17:15 OP139 EROSIVE AND NON
Page 77 and 78:
sYMPosIUM 08:30 - 10:30 S8/9 noTes:
Page 79 and 80:
08:40 - 08:50 OP163 DETECTION OF L
Page 81 and 82:
08:50 - 09:00 OP176 CAN WE SHORTEN
Page 83 and 84:
10:10 - 10:20 OP196 A RANDOMIZED CO
Page 85 and 86:
fRee PaPeR sessIon 11:00 - 12:30 S8
Page 87 and 88:
sYMPosIUM 11:00 - 12:30 N9/10 Do we
Page 89 and 90:
12:00 - 12:10 OP243 PREDICTION OF S
Page 91 and 92:
14:00 - 14:20 Molecular tools for e
Page 93 and 94:
14:40 - 14:50 OP261 DEVELOPMENT OF
Page 95 and 96:
16:25 - 16:45 Upper GI perforations
Page 97 and 98:
16:05 - 16:25 Community dyspepsia m
Page 99 and 100:
16:35 - 16:45 OP301 COMPARISON BETW
Page 101 and 102:
16:35 - 16:45 OP319 THE OMEGA3 PO
Page 103 and 104:
08:50 - 09:00 OP325 DISEASE ACTIVIT
Page 105 and 106:
08:30 - 08:50 How to treat: Best ev
Page 107 and 108:
10:00 - 10:10 OP350 HISTOPATHOLOGIC
Page 109 and 110:
09:40 - 09:50 OP372 A POSSIBLE TROP
Page 111 and 112:
12:20 - 12:30 OP393 MAJOR REDUCTION
Page 113 and 114:
11:40 - 12:00 Advances in treatment
Page 115 and 116:
11:30 - 11:40 OP420 THERAPEUTIC EFF
Page 117 and 118:
15:00 - 15:10 OP441 COMPARISON OF A
Page 119 and 120:
14:50 - 15:00 OP458 EFFECT OF BASEL
Page 121 and 122:
14:40 - 14:50 OP468 SENTINEL NODE P
Page 123 and 124:
Neurogastroenterology & Motility Al
Page 125 and 126:
LUNCH SESSIONS PER DAY
Page 127 and 128:
Room sG5 Preventing and managing si
Page 129 and 130:
POSTER SESSIONS PER DAY
Page 131 and 132:
P0012 EFFICACY OF THROMBINFIBRIN
Page 133 and 134:
P0033 USEFULLNESS OF NONINVASIVE
Page 135 and 136:
P0055 SIGNIFICANCE OF FUNGAL TRANS
Page 137 and 138:
P0079 CHANGES IN THE ExPRESSION OF
Page 139 and 140:
P0101 ExPRESSION OF THROMBOSPONDIN
Page 141 and 142:
P0121 VALIDITY OF ENDOSCOPIC SUBMUC
Page 143 and 144:
P0144 USEFULNESS OF ELECTROGASTROGR
Page 145 and 146:
P0168 COMPARISON BETWEEN ESD AND CO
Page 147 and 148:
P0189 HIGH RESOLUTION COMPUTED TOMO
Page 149 and 150:
P0211 SCREENING COLONOSCOPY IN FIRS
Page 151 and 152:
P0234 EMMPRIN, MATRIx METALLOPROTEI
Page 153 and 154:
P0258 SUCCESSFUL AMPLIFICATION OF C
Page 155 and 156:
P0279 COLONIC MUCOSAL CYTOkINE ExPR
Page 157 and 158:
P0301 FAMILIAL AND SPORADIC INFLAMM
Page 159 and 160:
P0320 PERIANAL DISEASE, SMALL BOWEL
Page 161 and 162:
P0343 ELAEAGNUS ANGUSTIFOLIA FRUIT
Page 163 and 164:
P0364 EFFECTS OF ANTIINFLAMMATORY
Page 165 and 166:
P0387 SUSTAINED EFFICACY OF ORAL PR
Page 167 and 168:
P0410 DEVELOPMENT OF CELLASSOCIAT
Page 169 and 170:
P0434 SECONDARY APPENDICEAL TUMOURS
Page 171 and 172:
P0458 EM2+ ELISA: A SEROLOGICAL TES
Page 173 and 174:
P0479 SERUM HEPCIDIN LEVELS IN ALCO
Page 175 and 176:
P0503 ENDOTOxIN BUT NOT BACTERIAL D
Page 177 and 178:
P0524 DISCRIMINATIVE ROLE OF THE NE
Page 179 and 180:
P0545 THE USEFULNESS OF NARROW BAND
Page 181 and 182:
P0567 UNSEDATED TRANSNASAL OESOPHA
Page 183 and 184:
P0590 QUALITY CONTROL OF COLONOSCOP
Page 185 and 186:
P0616 FAILED CANNULATION AFTER INIT
Page 187 and 188:
P0638 SPIRAL ENTEROSCOPY ERCP IN SU
Page 189 and 190:
P0662 ENDOSCOPIC FEATURES OF SMALL
Page 191 and 192:
P0684 THE VALUE OF REALTIME CONTR
Page 193 and 194:
P0707 A NOVEL SURGICAL TECHNIQUE US
Page 195 and 196:
P0730 OVERALL SUCCESS RATES IN THE
Page 197 and 198:
P0741 PREDICTION OF THE NEED FOR EN
Page 199 and 200:
P0763 THE HISTOLOGICAL DYNAMICS AND
Page 201 and 202:
PosTeR sessIon Intestinal disorders
Page 203 and 204:
P0807 HLA GENE DOSE EFFECT AND HELI
Page 205 and 206:
P0828 LTNS001, A NAPROxEN PRODR
Page 207 and 208:
P0852 COMPREHENSIVE EVALUATION OF I
Page 209 and 210:
P0877 E3710, A NEW PROTON PUMP INHI
Page 211 and 212:
P0900 OESOPHAGEAL CANCER PROFILE IN
Page 213 and 214:
P0921 GASTRIC EMPTYING MEASUREMENTS
Page 215 and 216:
P0942 UNDETECTED COLORECTAL CANCER
Page 217 and 218:
P0965 ASCITES ON CT SCAN IS A FACTO
Page 219 and 220:
P0987 THE SIGNIFICANCE OF MONITORIN
Page 221 and 222:
P1009 kINOME PROFILING OF INFLAMED
Page 223 and 224:
P1030 URINARY METABOLIC PROFILING S
Page 225 and 226:
P1051 THE PROFILE OF INFLAMMATORY B
Page 227 and 228:
P1071 EVIDENCE QUALITY ASSESSMENT F
Page 229 and 230:
P1092 A COMBINED DELAYED AND ExTEND
Page 231 and 232:
P1114 REDUCED MUCOSAL EOSINOPHIL AC
Page 233 and 234:
P1136 ANTICANCER EFFECTS OF ASTAxAN
Page 235 and 236:
P1159 DETECTION OF ADVANCED NEOPLAS
Page 237 and 238:
P1180 HISTOLOGICAL STEATOSIS PRESEN
Page 239 and 240:
P1203 TRANSFORMING GROWTH FACTOR BE
Page 241 and 242:
P1227 VALIDATION OF NAFLD FIBROSIS
Page 243 and 244:
P1251 PREDICTORS RELATED TO SURVIVA
Page 245 and 246:
P1275 MAGNIFYING ENDOSCOPIC FINDING
Page 247 and 248:
P1299 USEFULNESS OF MEASURING WIDTH
Page 249 and 250:
P1323 INCIDENCE OF BACTEREMIA AFTER
Page 251 and 252:
P1344 ERCP IN PATIENTS WITH BILLROT
Page 253 and 254:
P1366 THE PILLCAM© COLON CAPSULE F
Page 255 and 256:
P1389 IMAGING OF AN Ex VIVO PANCREA
Page 257 and 258:
P1413 LEPTIN AND ADIPONECTIN PLASMA
Page 259 and 260:
P1438 ENDOSCOPIC VISIBLE LIGHT SPEC
Page 261 and 262:
P1458 EFFICIENCY OF COMBINED ENDOSC
Page 263 and 264:
P1470 ASSOCIATION BETWEEN NONSTEROI
Page 265 and 266:
P1491 CORRELATION OF PEPSINOGEN I,
Page 267 and 268:
PosTeR sessIon Intestinal disorders
Page 269 and 270:
P1536 ARE HOSPITAL DOCTORS FORGETTI
Page 271 and 272:
P1557 ESOPHAGEAL BIOPSIES IN PATIEN
Page 273 and 274:
P1580 HISTOLOGICAL STUDY OF THE GAS
Page 275 and 276:
P1605 INCIDENCE OF GASTROESOPHAGEAL
Page 277 and 278:
P1628 PATTERNS OF LARYNGOPHARYNGEAL
Page 279 and 280:
PosTeR sessIon Paediatric gastroent
Page 281 and 282:
P1675 NEOANGIOGENESIS GOING WITH HE
Page 283 and 284:
P1699 THE UTILITY OF CONDITIONING S
Page 285 and 286:
P1722 PERIPHERAL TLYMPHOCYTES FRO
Page 287 and 288:
P1743 THE IMMUNODULATORY PROPERTIES
Page 289 and 290:
P1762 THE INCIDENCE OF COLORECTAL C
Page 291 and 292:
P1786 ENDOLUMINAL IMAGING OF COLITI
Page 293 and 294:
P1810 PROTECT1 STUDY OF INTESTINE
Page 295 and 296:
PosTeR sessIon nerve, gut and motil
Page 297 and 298:
P1852 LUBIPROSTONE INITIATES IMPROV
Page 299 and 300:
P1869 NEk2 AS A NOVEL MOLECULAR TAR
Page 301 and 302:
P1890 HIGH BMI, NON USE OF ASPIRIN
Page 303 and 304:
P1911 CURCUMIN PREVENTS LIVER FIBRO
Page 305 and 306:
P1932 DEGREE OF THROMBOCYTOPENIA AS
Page 307 and 308:
P1954 MUTATIONS IN PkR EIF2 ALPHA
Page 309 and 310:
P1975 ExTENDED TREATMENT DURATION O
Page 311 and 312:
P1995 EPIDEMIOLOGY AND RISk FACTORS
Page 313 and 314:
P2017 SEDATION DURING UPPER ENDOSCO
Page 315 and 316:
P2037 BASAL PROTRUSION OF ULCERS IN
Page 317 and 318:
P2059 RETROSPECTIVE AUDIT OF HEALTH
Page 319 and 320:
P2081 ENDOSCOPIC RETROGRADE CHOLAN
Page 321 and 322:
P2102 EUSFNA PREDICTS 5YEAR SUR
Page 323 and 324:
P2124 ANTISECRETORY FACTOR (AF) AFF
Page 325 and 326:
P2146 GLUCOSE TOLERANCE, INSULIN SE
Page 327 and 328:
P2167 RANDOMIZED CONTROLLED TRIAL C
Page 329 and 330:
GasTRo 2009 UeGW WcoG, london would
Page 331 and 332:
WORKING PARTY REPORTS
Page 333 and 334:
Wednesday, November 25, 2009 08:30
Page 335 and 336:
ESGE/OMED LEARNING AREA and ULTRASO
Page 337 and 338:
esGe/oMeD lecTURe THeaTRe Experts i
Page 339 and 340:
GasTRo 2009 PosTGRaDUaTe coURse: cl
Page 341 and 342:
COMMON INTEREST GROUP MEETINGS
Page 343 and 344:
15:40 - 16:30 Session 5: EU Guideli
Page 345 and 346:
13:50 - 14:10 Indian North-South sh
Page 347 and 348:
IBD infusion unit performance. The
Page 349 and 350:
EDMC: 5th workshop on severe GI Mot
Page 351 and 352:
BUSINESS MEETINGS and PRESS CONFERE
Page 353 and 354:
EAGE Saturday, November 21, 2009 14
Page 355 and 356:
SATELLITE SYMPOSIA and BREAKFAST ME
Page 357 and 358:
19:05 - 19:20 Double Ballon Endosco
Page 359:
Tuesday, November 24, 2009 18:00 -
Page 362 and 363:
GI nURses 2009 esGena/sIGnea lonDon
Page 364 and 365:
GI nURses 2009 PRoGRaMMe saTURDaY,
Page 366 and 367:
GI nURses 2009 - PRoGRaMMe oVeRVIeW
Page 368 and 369:
GI nURses 2009 - DeTaIleD PRoGRaMMe
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 381 and 382:
FUN RUN, PUBLIC HEALTH DAY and SUPP
Page 383 and 384:
RUnnInG TRack 343
Page 385 and 386:
Half- anD fUll-DaY ToURs Take advan
Page 387 and 388:
favourite Royal Residence of Queen
Page 389 and 390:
Tuesday, November 24, 2009 08:30 -
Page 391 and 392:
There are many coaching inns, inclu
Page 393 and 394:
Day 3 - Full day at leisure. you wi
Page 395 and 396:
and is home to the nationally known
Page 397 and 398:
LIST OF REVIEWERS
Page 399 and 400:
a Aabakken, Lars Abraldes, Juan G A
Page 401 and 402:
k Karagiannis, John A Kaser, Arthur
Page 403 and 404:
T Tack, Jan Tamori, Akihiro Tannapf
Page 405 and 406:
INDEX OF AUTHORS (CORE PROGRAMME)
Page 407 and 408:
a A, J.: P1590 Aabakken, L.: OP209
Page 409 and 410:
Alexander, S.M.: P1892 Alexandrakis
Page 411 and 412:
Arfini, C.: P0482 Argent, B.E.: OP4
Page 413 and 414:
Banaee, F.: P1244 Banai, J.: P0317,
Page 415 and 416:
Benizri, E.: P1420 Benjamin, J.: P1
Page 417 and 418:
Bojarski, C.: P0166 Bojic, D.: P178
Page 419 and 420:
Bromley, J.: OP213 Bronowicki, J.P.
Page 421 and 422:
Candel, F.J.: P2024 Candel Erenas,
Page 423 and 424:
Chan, K.W.: OP350 Chan, S.: OP073 C
Page 425 and 426:
Chun, H.J.: OP175, OP180*, OP376*,
Page 427 and 428:
Cosnes, J.: P1052, P1816 Coss-Adame
Page 429 and 430:
David, G.: P0317, P0318, P0320 Davi
Page 431 and 432:
DeOliveira, T.: P1412* Depoortere,
Page 433 and 434:
Doulgeroglou, V.G.: P0759 Douma, K.
Page 435 and 436:
Engel, H.: P0801 Engelen, S.M.E.: O
Page 437 and 438:
Ferrante, M.: P0328, P0351, P1044 F
Page 439 and 440:
Froehlich, F.: P0308, P1087, P1091,
Page 441 and 442:
Gebel, M.J.: OP354, P0486, P1259 Ge
Page 443 and 444:
Gordillo, J.: P1082, P1083, P1751,
Page 445 and 446:
Habbema, D.J.D.: P0427 Haber, G.: 5
Page 447 and 448:
Healy, L.A.: P0088, P0153, P1676 He
Page 449 and 450:
Horak, J.: OP193* Horev, N.: P0039
Page 451 and 452:
Illueca, M.: P0926, P0928, P0929 Il
Page 453 and 454:
Jelev, D.T.: P0514 Jelsness-Jørgen
Page 455 and 456:
Kalantzis, N.: P0175, P0896, P0977*
Page 457 and 458:
Kelly, C.: P1666 Kelly, D.: P0201 K
Page 459 and 460:
Kindt, S.: OP273*, P0133, P1838 Kin
Page 461 and 462:
Koutsoumpas, A.L.: P0759, P1179 Kov
Page 463 and 464:
Laheij, R.J.: P0961 Laheij, R.J.F.:
Page 465 and 466:
Lee, S.: OP291, OP470*, P0237, P040
Page 467 and 468:
Lindblad, M.: P2120 Lindegren, H.:
Page 469 and 470:
M Ma, C.: P1758 Ma, S.: P0458 Ma, X
Page 471 and 472:
Marcelis, Q.: OP056 Marchese, A.: P
Page 473 and 474:
Mayberry, J.: P1792 Mayberry, J.F.:
Page 475 and 476:
Milla, P.: OP261 Milla, P.J.: OP182
Page 477 and 478:
Moreira, M.J.: P1023*, P2105 Moreir
Page 479 and 480:
Nagtegaal, I.D.: P1142, P1146* Nagy
Page 481 and 482:
Ninomiya, S.: P0547 Nio, C.: OP250*
Page 483 and 484:
Okamoto, N.: P1459 Okamoto, R.: OP0
Page 485 and 486:
Pahuja, S.: P0521 Paik, C.: P2181 P
Page 487 and 488:
Pazurek, M.: P0233 Pearce, C.: P207
Page 489 and 490:
Pironi, L.: 56 Pirozzi, C.: P0297 P
Page 491 and 492:
Pucci, M.: P0067 Puente, J.J.: P115
Page 493 and 494:
Reinisch, W.: OP151, OP323, P0315,
Page 495 and 496:
Rossi, M.: OP379, P2187 Rosso, L.:
Page 497 and 498:
Salimullah, A.: P0242 Salines, E.:
Page 499 and 500:
Schäfer, K.: OP085* Schäfer, M.:
Page 501 and 502:
Shaposhnikova, N.A.: P0492, P1919 S
Page 503 and 504:
Širca-Čampa, A.: P1540 Siriwardan
Page 505 and 506:
Spieker, T.: OP308* Spiers, H.: OP1
Page 507 and 508:
Sutton, R.: OP281 Suzuki, D.: P0676
Page 509 and 510:
Tappenden, K.A.: OP141, P0814 Tardi
Page 511 and 512:
Tondi, P.: P1797 Tondu, F.: P1548 T
Page 513 and 514:
Uchiyama, Y.: OP042 Udani, B.: P101
Page 515 and 516:
Van Lommel, L.: P1031* Van Loo, D.:
Page 517 and 518:
Visokai, V.: P0706 Visschers, R.G.J
Page 519 and 520:
Wernersson, B.: P0926 Wesdorp, E.I.
Page 521 and 522:
Yamagami, H.: P0663 Yamagata, T.: P
Page 523 and 524:
Zagainov, V.: P1993 Zagainova, E.:
Page 525 and 526:
LIST OF EXHIBITORS
Page 527 and 528:
are seiten kument)
Page 529 and 530:
PLANS OF EXCEL LONDON
Page 531 and 532:
flooR Plan scIenTIfIc coRe PRoGRaMM
Page 533 and 534:
flooR Plan GI nURses 2009 esGena/sI
Page 535 and 536:
flooR Plan PUblIc HealTH DaY 495
show all

Table of conTenTs Welcome address II about GasTRo 2009, UeGW ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?